Literature DB >> 20180109

Intranasal fentanyl versus placebo for pain in children during catheterization for voiding cystourethrography.

Seen Chung1, Ruth Lim, Ran D Goldman.   

Abstract

BACKGROUND: Voiding cystourethrogram (VCUG) is a common procedure at pediatric tertiary care centres that can be painful as it involves a urinary catheter. Currently there are no widely utilized protocols for non-topical medications to decrease pain that children feel during catheterization.
OBJECTIVE: To determine if intranasal (IN) fentanyl is effective at decreasing pain that children feel during catheterization of VCUG when compared with sterile water.
MATERIALS AND METHODS: We performed a double-blind randomized controlled trial, using IN fentanyl (2 microg/kg) compared to placebo (sterile water,) in children 4-8 years of age scheduled for elective VCUG in one urban pediatric tertiary center.
RESULTS: Using the Face Pain Score-Revised, children receiving IN fentanyl scored 2.58 (1.93-3.25 95% CI) while those receiving sterile water scored 2.86 (2.20-3.51 95% CI) showing no statistically significant difference. There were no adverse events.
CONCLUSIONS: Although we were unable to show a statistically significant difference between our study and control groups, we believe that this may be due to technique (positioning, delivery device) and timing of administration of IN fentanyl as well as multi-factorial causes of distress during VCUG. Future studies investigating alternative delivery techniques of IN fentanyl for analgesia during VCUG may yield more promising results.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20180109     DOI: 10.1007/s00247-009-1521-1

Source DB:  PubMed          Journal:  Pediatr Radiol        ISSN: 0301-0449


  23 in total

1.  Voiding ability using propofol sedation in children undergoing voiding cystourethrograms: a retrospective analysis.

Authors:  Paul A Merguerian; Sean T Corbett; Joseph Cravero
Journal:  J Urol       Date:  2006-07       Impact factor: 7.450

2.  Intranasal fentanyl reduces acute pain in children in the emergency department: a safety and efficacy study.

Authors:  Meredith L Borland; Ian Jacobs; Gary Geelhoed
Journal:  Emerg Med (Fremantle)       Date:  2002-09

3.  Intranasal fentanyl provides adequate postoperative analgesia in pediatric patients.

Authors:  Ray Manjushree; Aparna Lahiri; Bablu Rani Ghosh; Arpita Laha; Krishna Handa
Journal:  Can J Anaesth       Date:  2002-02       Impact factor: 5.063

4.  Premedication with midazolam in young children: a comparison of four routes of administration.

Authors:  Alexander Kogan; Jacob Katz; Rachel Efrat; Leonid A Eidelman
Journal:  Paediatr Anaesth       Date:  2002-10       Impact factor: 2.556

5.  Use of intranasal fentanyl in children undergoing myringotomy and tube placement during halothane and sevoflurane anesthesia.

Authors:  J L Galinkin; L M Fazi; R M Cuy; R M Chiavacci; C D Kurth; U K Shah; I N Jacobs; M F Watcha
Journal:  Anesthesiology       Date:  2000-12       Impact factor: 7.892

6.  Premedication during micturating cystourethrogram to achieve sedation and anxiolysis.

Authors:  Ipek Akil; Mine Ozkol; Ozge Yilmaz Ikizoglu; Muzaffer Polat; Ozum Yuksel Tuncyurek; Oryal Taskin; Hasan Yuksel
Journal:  Pediatr Nephrol       Date:  2005-05-13       Impact factor: 3.714

7.  Patient-controlled intranasal analgesia: effective alternative to intravenous PCA for postoperative pain relief.

Authors:  S Toussaint; J Maidl; R Schwagmeier; H W Striebel
Journal:  Can J Anaesth       Date:  2000-04       Impact factor: 5.063

8.  The effects of intranasal midazolam on urodynamic studies in children.

Authors:  P Bozkurt; N Kilic; G Kaya; Y Yeker; M Elicevik; Y Söylet
Journal:  Br J Urol       Date:  1996-08

9.  Intranasal fentanyl titration for postoperative pain management in an unselected population.

Authors:  H W Striebel; J Pommerening; A Rieger
Journal:  Anaesthesia       Date:  1993-09       Impact factor: 6.955

10.  Premedication with oral midazolam for voiding cystourethrography in children: safety and efficacy.

Authors:  J S Elder; R Longenecker
Journal:  AJR Am J Roentgenol       Date:  1995-05       Impact factor: 3.959

View more
  7 in total

1.  Intranasal sumatriptan for migraine in children.

Authors:  Ran D Goldman; Garth D Meckler
Journal:  Can Fam Physician       Date:  2015-05       Impact factor: 3.275

2.  Long-term efficacy and tolerability of intranasal fentanyl in the treatment of breakthrough cancer pain.

Authors:  Sebastiano Mercadante; Renato Vellucci; Arturo Cuomo; Claudio Adile; Andrea Cortegiani; Alessandro Valle; Patrizia Villari; Alessandra Casuccio
Journal:  Support Care Cancer       Date:  2014-10-29       Impact factor: 3.603

Review 3.  Sedation and Analgesia Using Medications Delivered via the Extravascular Route in Children Undergoing Laceration Repair.

Authors:  Jamie L Miller; Amanda C Capino; Amber Thomas; Kevin Couloures; Peter N Johnson
Journal:  J Pediatr Pharmacol Ther       Date:  2018 Mar-Apr

Review 4.  Non-Intravenous Sedatives and Analgesics for Procedural Sedation for Imaging Procedures in Pediatric Patients.

Authors:  Amber Thomas; Jamie L Miller; Kevin Couloures; Peter N Johnson
Journal:  J Pediatr Pharmacol Ther       Date:  2015 Nov-Dec

Review 5.  Intranasal fentanyl for the management of acute pain in children.

Authors:  Adrian Murphy; Ronan O'Sullivan; Abel Wakai; Timothy S Grant; Michael J Barrett; John Cronin; Siobhan C McCoy; Jeffrey Hom; Nandini Kandamany
Journal:  Cochrane Database Syst Rev       Date:  2014-10-10

6.  Intranasal fentanyl versus intravenous morphine in the emergency department treatment of severe painful sickle cell crises in children: study protocol for a randomised controlled trial.

Authors:  Michael Joseph Barrett; John Cronin; Adrian Murphy; Siobhan McCoy; John Hayden; SinéadNic an Fhailí; Tim Grant; Abel Wakai; Corrina McMahon; Sean Walsh; Ronan O'Sullivan
Journal:  Trials       Date:  2012-05-30       Impact factor: 2.279

Review 7.  Urodynamic studies for management of urinary incontinence in children and adults.

Authors:  Keiran David Clement; Marie Carmela M Lapitan; Muhammad Imran Omar; Cathryn M A Glazener
Journal:  Cochrane Database Syst Rev       Date:  2013-10-29
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.